GLP-1 Pills: Novo Nordisk vs. Eli Lilly
Novo Nordisk is gaining ground in the oral GLP-1 space, forcing a rethink of Eli Lilly's long-assumed dominance. For patients considering weight loss medications, this shift could change what options are available, how much they cost, and which providers recommend what. Here's what you need to know right now.